Jasvinder A Singh Selected Research

Arthritis (Polyarthritis)

12/2023	Erratum to "2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective" [The Journal of Arthroplasty 38 (2023) 2193-2201].
11/2023	2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective.
11/2023	2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective.
11/2023	2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective.
1/2022	2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
1/2022	2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
1/2022	2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
1/2021	Experience and impact of crystal pyrophosphate deposition (CPPD) from a patient and caregiver perspective: A qualitative exploration from the OMERACT CPPD working group.
1/2021	Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working group.
10/2019	Association of Race/Ethnicity With Hospital Discharge Disposition After Elective Total Knee Arthroplasty.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jasvinder A Singh Research Topics

Disease

98	Gout 01/2023 - 06/2007
76	Pain (Aches) 01/2024 - 01/2005
65	Rheumatoid Arthritis 05/2024 - 01/2009
42	Infections 05/2024 - 01/2009
30	Osteoarthritis 12/2023 - 10/2010
28	Arthritis (Polyarthritis) 12/2023 - 04/2005
18	Rheumatic Diseases (Rheumatism) 12/2023 - 03/2013
13	Neoplasms (Cancer) 05/2024 - 01/2010
13	Inflammation (Inflammations) 01/2023 - 10/2009
11	Arthralgia (Joint Pain) 12/2021 - 02/2009
10	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 01/2018
10	Stroke (Strokes) 10/2023 - 01/2010
9	Hypertension (High Blood Pressure) 01/2021 - 09/2010
8	COVID-19 02/2024 - 01/2020
8	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2024 - 01/2017
8	Heart Failure 10/2023 - 01/2010
8	Hyperuricemia 01/2021 - 03/2010
7	Tuberculosis (Tuberculoses) 05/2024 - 01/2010
7	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 01/2017
7	Periprosthetic Fractures 05/2015 - 10/2011
6	Osteonecrosis (Kienbock's Disease) 12/2023 - 09/2013
6	Myocardial Infarction 10/2023 - 01/2010
6	Necrosis 10/2016 - 01/2010
5	Acquired Immunodeficiency Syndrome (AIDS) 11/2023 - 12/2010
5	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2017
5	Obesity 01/2021 - 12/2009
5	Gouty Arthritis 11/2019 - 04/2009
5	Dementia (Dementias) 11/2018 - 01/2018
5	Ankylosing Spondylitis 01/2017 - 05/2007
5	Shoulder Pain 01/2014 - 05/2009
4	Fatigue 01/2024 - 12/2007
4	Hypersensitivity (Allergy) 12/2023 - 01/2020
4	Diabetes Mellitus 11/2023 - 11/2018
4	Crystal Arthropathies 10/2022 - 01/2020
4	Lung Diseases (Lung Disease) 01/2021 - 10/2011
4	Chronic Renal Insufficiency 01/2021 - 01/2017
4	Renal Insufficiency (Renal Failure) 01/2021 - 06/2007
4	Knee Osteoarthritis 05/2014 - 04/2010
3	Musculoskeletal Diseases (Musculoskeletal Disease) 12/2023 - 01/2005
3	Pneumonia (Pneumonitis) 01/2022 - 05/2012
3	Coronary Disease (Coronary Heart Disease) 11/2021 - 02/2016
3	Substance-Related Disorders (Drug Abuse) 07/2021 - 01/2017
3	Disease Progression 01/2021 - 10/2017

Drug/Important Bio-Agent (IBA)

67	Uric Acid (Urate)IBA 01/2024 - 06/2007
40	Allopurinol (Remid)FDA LinkGeneric 01/2022 - 06/2007
33	Antirheumatic Agents (DMARD)IBA 05/2024 - 07/2004
22	Febuxostat FDA Link 01/2022 - 01/2010
10	Methotrexate (Mexate)FDA LinkGeneric 12/2023 - 06/2013
9	Etanercept (Enbrel)FDA Link 01/2023 - 11/2009
9	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 05/2010
9	GlucocorticoidsIBA 01/2022 - 09/2016
9	Type A Botulinum Toxins (Botox)FDA Link 01/2014 - 02/2009
8	Opioid Analgesics (Opioids)IBA 01/2023 - 01/2005
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2011
8	Infliximab (Remicade)FDA Link 10/2016 - 11/2009
7	Tumor Necrosis Factor InhibitorsIBA 01/2024 - 02/2011
7	Adalimumab (Humira)FDA Link 01/2023 - 11/2009
7	ametantrone (HAQ)IBA 10/2022 - 07/2011
7	Colchicine FDA LinkGeneric 02/2021 - 06/2007
7	3,5-tetrahydroaldosterone sulfate (THAS)IBA 03/2020 - 05/2010
7	Abatacept (Orencia)FDA Link 10/2016 - 10/2009
6	VaccinesIBA 02/2024 - 01/2016
6	Rituximab (Mabthera)FDA Link 01/2023 - 11/2009
6	ORALIT (ORS)IBA 03/2020 - 08/2011
6	theasinensin AIBA 01/2020 - 10/2010
6	tofacitinibIBA 10/2017 - 01/2016
6	tocilizumab (atlizumab)FDA Link 05/2016 - 01/2010
6	golimumab FDA Link 05/2016 - 01/2010
6	incobotulinumtoxinA FDA Link 01/2014 - 05/2009
5	Janus Kinase InhibitorsIBA 12/2023 - 01/2019
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 03/2009
5	Pegloticase FDA Link 12/2020 - 03/2010
5	DiureticsIBA 10/2019 - 09/2010
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2019 - 01/2018
5	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 05/2016 - 01/2009
4	Analgesics (Analgesic Drugs)IBA 01/2021 - 10/2009
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2019 - 01/2018
4	Botulinum Toxins (Botulinum Toxin)IBA 01/2013 - 04/2010
3	InterleukinsIBA 01/2023 - 02/2011
3	CytokinesIBA 01/2023 - 01/2009
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2015
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 07/2010
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022 - 03/2011
3	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2021 - 07/2004
3	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2021 - 01/2020

Therapy/Procedure

74	Therapeutics 01/2024 - 06/2007
43	Knee Replacement Arthroplasty (Total Knee Replacement) 12/2023 - 03/2011
29	Arthroplasty 12/2023 - 11/2008
23	Hip Replacement Arthroplasty (Total Hip Replacement) 11/2023 - 12/2009
20	Length of Stay 01/2022 - 05/2012
9	Ambulatory Care (Outpatient Care) 01/2022 - 06/2011
8	Intra-Articular Injections 11/2023 - 03/2009
8	Reoperation 01/2021 - 07/2013
8	Injections 01/2021 - 02/2009
8	Activities of Daily Living (ADL) 01/2020 - 04/2005
7	Replacement Arthroplasty 12/2022 - 10/2009
5	Diet Therapy (Therapy, Diet) 08/2020 - 03/2014
4	Glycemic Control 11/2023 - 01/2019
4	Physical Therapy Modalities (Physical Therapy Technique) 11/2023 - 04/2010
4	Biological Therapy 01/2017 - 01/2009